NATERA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.3 USD | +10.19% |
|
+8.57% | +68.09% |
| May. 10 | Baird Adjusts Natera Price Target to $117 From $99, Maintains Outperform Rating | MT |
| May. 10 | UBS Boosts Price Target on Natera to $160 From $104, Keeps Buy Rating | MT |
Presenter SpeechUnknown Analyst (Analysts)All right. So it's good to see a stack house on day ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Natera, Inc. is a diagnostics company, which is focused on the development and commercialization of molecular testing services, applying its technology in the fields of womenâs health, oncology and organ health. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Companyâs algorithms and bioinformatics in order to validate and launch tests based on the Companyâs technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.
Calendar
2024-05-17
- ACOG Clinical & Scientific Meeting
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
105.3
USD
Average target price
118.7
USD
Spread / Average Target
+12.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +68.09% | 12.87B | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +9.23% | 29.06B | |
| -8.63% | 17.51B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +6.43% | 12.77B | |
| +68.23% | 12.42B |
- Stock Market
- Equities
- NTRA Stock
- News Natera, Inc.
- Transcript : Natera, Inc. Presents at Cowen 43rd Annual Healthcare Conference, Mar-08-2023 11